USPTO 2015–2025 USPTO PatentsView US Corporation

Acclarent, Inc.

USPTO PatentsView assignee record — 272 granted patents across 31 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

272
Total patents granted
31
CPC technology areas
17.6
Avg claims per patent
+29%
5-year filing velocity

Portfolio overview

Acclarent, Inc. has been granted 272 US utility patents between 2015 and 2025, placing Acclarent, Inc. at rank #1,531 across all assignees tracked by PlainPatent. This portfolio spans 31 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.6 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Acclarent, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 54.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 153 grants, compared with 119 in the 2015–2019 window — a +29% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Acclarent, Inc.'s 17.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 31 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Acclarent, Inc. against peers pursuing similar technology classes.

How does Acclarent compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Acclarent holds 272 patents — placing it at rank #1,531 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

10203040 20152016201720182019202020212022202320242025 14
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Acclarent, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 27 9.9%
2016 17 6.3%
2017 23 8.5%
2018 25 9.2%
2019 27 9.9%
2020 37 13.6%
2021 34 12.5%
2022 23 8.5%
2023 24 8.8%
2024 21 7.7%
2025 14 5.1%

Which technologies does Acclarent, Inc. patent most?

Top 15 of 31 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#1,531

Across all tracked assignees

Innovation Score

54.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Acclarent, Inc. hold?
Acclarent, Inc. holds 272 US granted patents filed between 2015 and 2025, spanning 31 technology areas.
What is Acclarent, Inc.'s Innovation Score?
Acclarent, Inc. has an Innovation Score of 54.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Acclarent, Inc. focus on?
Acclarent, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 244 patents. The company has filed patents in 31 CPC subclasses total.
Is Acclarent, Inc.'s patent filing rate increasing or decreasing?
Acclarent, Inc.'s recent filing velocity is +29% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Acclarent, Inc.'s patents?
Acclarent, Inc.'s patents average 17.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Acclarent, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope